1. 0918 Amiloride treatment ameliorates MRI surrogate markers of neurodegeneration in primary progressive multiple sclerosis. Issue 3 (9th February 2012) Authors: Arun, T; Sbdarella, E; Ruiter, M; Tomassini, V; Leite, M I; Craner, M; Fugger, L; Jenkinson, M; Palace, J Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83:Issue 3(2012) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 139 Comparison of histological and diffusion-weighted MRI techniques in the analysis of post mortem multiple sclerosis brains. Issue 3 (9th February 2012) Authors: Kolasinski, J; Stagg, C J; Chance, S; Esiri, M; Chang, E; Palace, J A; McNab, J A; Jenkinson, M; Miller, K; Johansen-Berg, H Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83:Issue 3(2012) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 630 Management and Outcomes of Primary Central Nervous System Lymphoma – Time to Improve the Patient Pathway. (4th May 2021) Authors: Norrington, M; Kumar, S; Islim, A; Smith, J; Husband, D; Mills, S; Jenkinson, M Journal: British journal of surgery Issue: Volume 108(2021)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Onsite and offsite bound states of the discrete nonlinear Schrödinger equation and the Peierls–Nabarro barrier. (22nd December 2015) Authors: Jenkinson, M; Weinstein, M I Journal: Nonlinearity Issue: Volume 29:Number 1(2016:Jan.) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OS03.5.A Corelation between longitudinal t2 MRI radiomic primary texture feature values and radiation dose in non-tumoral regions of the brain in paediatric brain tumours. (9th September 2021) Authors: Sakhavalkar, P; Avula, S; Pizer, B; Thorp, N; Jenkinson, M Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P01.100 Tumour treating fields: Acceptable, tolerable, and can we reduce cost?. (19th September 2018) Authors: Brodbelt, A; Williams, M; Thorpe, A; Mills, S; Price, S; Lekka, E; Watts, C; Davies, C; Jenkinson, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. POD02 Predicting brain atrophy at 1 year by baseline multimodal MRI data. Issue 11 (22nd October 2010) Authors: Tarunya, A; Smith, S; Jenkinson, M; Palace, J A; Beckmann, C Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 81:Issue 11(2010) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. POI01 Direct comparison of multiple nonlesional imaging measures to assess their power to measure treatment effects over 1 year in primary progressive multiple sclerosis. Issue 11 (22nd October 2010) Authors: Arun, T; Smith, S; Weir, A P; Palace, J; Jenkinson, M Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 81:Issue 11(2010) Page Start: e52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗